Puhr-Westerheide, Daniel https://orcid.org/0000-0003-3669-5572
Cyran, Clemens C.
Sargsyan-Bergmann, Josef
Todica, Andrei
Gildehaus, Franz-Josef
Kunz, Wolfgang G.
Stahl, Robert
Spitzweg, Christine
Ricke, Jens
Kazmierczak, Philipp M.
Article History
Received: 30 July 2019
Accepted: 7 November 2019
First Online: 14 November 2019
Ethics approval and consent to participate
: This retrospective study was approved by the Institutional Review Board and the requirement for informed consent was waived. Written informed consent for the diagnostic <sup>18</sup>F-DOPA PET/CT scan and the contrast-enhanced MRI scan was obtained from all patients prior to the examination.
: Not applicable.
: The following competing interests are declared: C. S.: honoraria for lectures and advisory boards from Eisai Co., Ltd., Ipsen Biopharmaceuticals, Inc., and Sanofi Genzyme Co. The other authors declare no competing interest.